BCPC Stock - Balchem Corporation
Unlock GoAI Insights for BCPC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $953.68M | $922.44M | $942.36M | $799.02M | $703.64M |
| Gross Profit | $336.21M | $302.06M | $280.45M | $243.17M | $223.90M |
| Gross Margin | 35.3% | 32.7% | 29.8% | 30.4% | 31.8% |
| Operating Income | $182.91M | $159.19M | $145.19M | $127.50M | $111.15M |
| Net Income | $128.47M | $108.54M | $105.37M | $96.10M | $84.62M |
| Net Margin | 13.5% | 11.8% | 11.2% | 12.0% | 12.0% |
| EPS | $3.97 | $3.38 | $3.29 | $2.98 | $2.63 |
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 5th 2025 | Rothschild & Co Redburn | Initiation | Neutral | $162 |
Earnings History & Surprises
BCPCEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 22, 2026 | — | — | — | — |
Q1 2026 | Feb 20, 2026 | $1.29 | — | — | — |
Q4 2025 | Oct 21, 2025 | $1.36 | $1.35 | -0.7% | ✗ MISS |
Q3 2025 | Jul 31, 2025 | $1.25 | $1.27 | +1.6% | ✓ BEAT |
Q2 2025 | Apr 24, 2025 | $1.25 | $1.22 | -2.4% | ✗ MISS |
Q1 2025 | Feb 21, 2025 | $1.11 | $1.03 | -7.2% | ✗ MISS |
Q4 2024 | Oct 25, 2024 | $1.11 | $1.13 | +1.8% | ✓ BEAT |
Q3 2024 | Jul 26, 2024 | $1.03 | $1.09 | +5.8% | ✓ BEAT |
Q2 2024 | May 3, 2024 | $0.98 | $1.03 | +5.1% | ✓ BEAT |
Q1 2024 | Feb 16, 2024 | $0.93 | $0.95 | +2.2% | ✓ BEAT |
Q4 2023 | Oct 27, 2023 | $0.97 | $1.04 | +7.2% | ✓ BEAT |
Q3 2023 | Jul 28, 2023 | $0.84 | $1.06 | +26.2% | ✓ BEAT |
Q2 2023 | Apr 28, 2023 | $0.78 | $0.70 | -10.3% | ✗ MISS |
Q1 2023 | Feb 24, 2023 | $0.90 | $0.66 | -26.7% | ✗ MISS |
Q4 2022 | Nov 4, 2022 | $0.85 | $1.00 | +17.6% | ✓ BEAT |
Q3 2022 | Jul 29, 2022 | $0.91 | $1.07 | +17.6% | ✓ BEAT |
Q2 2022 | Apr 29, 2022 | $0.79 | $1.03 | +30.4% | ✓ BEAT |
Q1 2022 | Feb 18, 2022 | $0.85 | $0.85 | 0.0% | = MET |
Q4 2021 | Oct 29, 2021 | $0.90 | $0.92 | +2.2% | ✓ BEAT |
Q3 2021 | Jul 30, 2021 | $0.88 | $0.93 | +5.7% | ✓ BEAT |
Latest News
Rothschild & Co Initiates Coverage On Balchem with Neutral Rating, Announces Price Target of $162
➖ NeutralHC Wainwright & Co. Maintains Buy on Balchem, Raises Price Target to $190
📈 PositiveBalchem Q3 Adj. EPS $1.35 Beats $1.31 Estimate, Sales $267.558M Beat $258.282M Estimate
📈 PositiveFrequently Asked Questions about BCPC
What is BCPC's current stock price?
What is the analyst price target for BCPC?
What sector is Balchem Corporation in?
What is BCPC's market cap?
Does BCPC pay dividends?
Similar Stocks
Basic Materials SectorExplore stocks similar to BCPC for comparison